{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:33:57Z","timestamp":1791488037218,"version":"4.3.4"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Inflammasome overactivation, multiprotein complexes that trigger inflammatory\nresponses, plays a critical role in Major Depressive Disorder (MDD) pathogenesis and treatment\nresponses. Indeed, different antidepressants alleviate depression-related behaviours by specifically\ncounteracting the NLRP3 inflammasome signalling pathway. The immunomodulatory effects of vortioxetine\n(VTX), a multimodal antidepressant with cognitive benefits, were recently revealed to counter\nmemory impairment induced by a peripheral lipopolysaccharide (LPS) injection 24 hours (h) postchallenge.\nThe potential link between VTX and NLRP3, along with other inflammasomes, remains\nun-explored.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The potential link between VTX and NLRP3, along with other inflammasomes, remains unexplored.\nHence, adult C57BL\/6J male mice (n = 73) were fed with a standard or VTX-enriched diet\n(600 mg\/kg of food, 28 days), injected with LPS (830 \u03bcg\/kg) or saline, and sacrificed 6\/24 h post-LPS.\nAt these time-points, transcriptional effects of LPS and VTX on NLRP3, NLRP1, NLRC4, AIM2 (inflammasomes),\nASC and CASP1 (related subunits) and NEK7 mediator (NLRP3 regulator) were assessed\nin dorsal and ventral hippocampal subregions, frontal-prefrontal cortex and hypothalamus,\nbrain regions serving behavioural-cognitive functions impaired in MDD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Varied expression patterns of inflammasomes were revealed, with long-term NLRP3 and\nASC transcriptional changes observed in response to LPS. It was demonstrated that VTX counteracted\nthe LPS-mediated NLRP3 and ASC upregulation in memory-related brain areas like the dorsal hippocampus\nat 24 h time-point, potentially via regulating NEK7 expression. No VTX-mediated transcriptional\neffects were observed on other inflammasomes, reinforcing a potentially specific modulation on\nthe NLRP3 inflammasome signalling pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Thus, a novel VTX molecular mechanism in modulating the NLRP3 inflammasome in a\ntime- and area-specific manner in the brain was highlighted, with significant clinical implications in\ntreating depression and cognitive impairments.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x22666240705143649","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:02:03Z","timestamp":1721030523000},"page":"196-208","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Time- and Region-specific Effect of Vortioxetine on Central LPS-induced Transcriptional Regulation of NLRP3 Inflammasome"],"prefix":"10.2174","volume":"23","author":[{"given":"Miriam","family":"Ciani","sequence":"first","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Rigillo","sequence":"additional","affiliation":[{"name":"Department of Biomedical,\nMetabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Centre of Neuroscience\nand Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Benatti","sequence":"additional","affiliation":[{"name":"Department of Biomedical,\nMetabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Centre of Neuroscience\nand Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pani","sequence":"additional","affiliation":[{"name":"Department of Biomedical,\nMetabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Department of Psychiatry and Behavioral\nSciences, University of Miami, Miami, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.C.","family":"Blom","sequence":"additional","affiliation":[{"name":"Department of Biomedical,\nMetabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Centre of Neuroscience\nand Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Brunello","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Tascedda","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Centre of Neuroscience\nand Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"CIB, Consorzio Interuniversitario Biotecnologie, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Alboni","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Centre of Neuroscience\nand Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Liu Q.","year":"2020","unstructured":"Liu Q.; He H.; Yang J.; Feng X.; Zhao F.; Lyu J.; Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. J Psychiatr Res  2020,126,134-140","journal-title":"J Psychiatr Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bjc.12333","volume":"61","author":"Shorey S.","year":"2022","unstructured":"Shorey S.; Ng E.D.; Wong C.H.J.; Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta\u2010analysis. Br J Clin Psychol  2022,61(2),287-305","journal-title":"Br J Clin Psychol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4088\/JCP.tk16043ah5c","volume":"78","author":"Culpepper L.","year":"2017","unstructured":"Culpepper L.; Lam R.W.; McIntyre R.S.; Cognitive impairment in patients with depression: Awareness, assessment, and management. J Clin Psychiatry  2017,78(9),1383-1394","journal-title":"J Clin Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1017\/S1092852918001207","volume":"24","author":"Pan Z.","year":"2019","unstructured":"Pan Z.; Park C.; Brietzke E.; Zuckerman H.; Rong C.; Mansur R.B.; Fus D.; Subramaniapillai M.; Lee Y.; McIntyre R.S.; Cognitive impairment in major depressive disorder. CNS Spectr  2019,24(1),22-29","journal-title":"CNS Spectr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/acps.13385","volume":"145","author":"Varghese S.","year":"2022","unstructured":"Varghese S.; Frey B.N.; Schneider M.A.; Kapczinski F.; de Azevedo Cardoso T.; Functional and cognitive impairment in the first episode of depression: A systematic review. Acta Psychiatr Scand  2022,145(2),156-185","journal-title":"Acta Psychiatr Scand"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"pyv082","DOI":"10.1093\/ijnp\/pyv082","volume":"19","author":"Rosenblat J.D.","year":"2016","unstructured":"Rosenblat J.D.; Kakar R.; McIntyre R.S.; The cognitive effects of antidepressants in major depressive disorder: A systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol  2016,19(2),pyv082","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"Kopschina Feltes P.","year":"2017","unstructured":"Kopschina Feltes P.; Doorduin J.; Klein H.C.; Ju\u00e1rez-Orozco L.E.; Dierckx R.A.J.O.; Moriguchi-Jeckel C.M.; de Vries E.F.J.; Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol  2017,31(9),1149-1165","journal-title":"J Psychopharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"106625","DOI":"10.1016\/j.phrs.2022.106625","volume":"187","author":"Xia C.Y.","year":"2023","unstructured":"Xia C.Y.; Guo Y.X.; Lian W.W.; Yan Y.; Ma B.Z.; Cheng Y.C.; Xu J.K.; He J.; Zhang W.K.; The NLRP3 inflammasome in depression: Potential mechanisms and therapies. Pharmacol Res  2023,187,106625","journal-title":"Pharmacol Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"109916","DOI":"10.1016\/j.intimp.2023.109916","volume":"117","author":"Roy S.","year":"2023","unstructured":"Roy S.; Arif Ansari M.; Choudhary K.; Singh S.; NLRP3 inflammasome in depression: A review. Int Immunopharmacol  2023,117,109916","journal-title":"Int Immunopharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","volume":"36","author":"Alcocer-G\u00f3mez E.","year":"2014","unstructured":"Alcocer-G\u00f3mez E.; de Miguel M.; Casas-Barquero N.; N\u00fa\u00f1ez-Vasco J.; S\u00e1nchez-Alcazar J.A.; Fern\u00e1ndez-Rodr\u00edguez A.; Cordero M.D.; NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun  2014,36,111-117","journal-title":"Brain Behav Immun"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phrs.2017.04.028","volume":"121","author":"Alcocer-G\u00f3mez E.","year":"2017","unstructured":"Alcocer-G\u00f3mez E.; Casas-Barquero N.; Williams M.R.; Romero-Guillena S.L.; Ca\u00f1adas-Lozano D.; Bull\u00f3n P.; S\u00e1nchez-Alcazar J.A.; Navarro-Pando J.M.; Cordero M.D.; Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder. Pharmacol Res  2017,121,114-121","journal-title":"Pharmacol Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"Guo H.","year":"2015","unstructured":"Guo H.; Callaway J.B.; Ting J.P.Y.; Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat Med  2015,21(7),677-687","journal-title":"Nat Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"pyw037","DOI":"10.1093\/ijnp\/pyw037","volume":"19","author":"Du R.H.","year":"2016","unstructured":"Du R.H.; Tan J.; Sun X.Y.; Lu M.; Ding J.H.; Hu G.; Fluoxetine inhibits NLRP3 inflammasome activation: Implication in depression. Int J Neuropsychopharmacol  2016,19(9),pyw037","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3389\/fimmu.2019.01511","volume":"10","author":"Arioz B.I.","year":"2019","unstructured":"Arioz B.I.; Tastan B.; Tarakcioglu E.; Tufekci K.U.; Olcum M.; Ersoy N.; Bagriyanik A.; Genc K.; Genc S.; Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1\/Nrf2 pathway. Front Immunol  2019,10,1511","journal-title":"Front Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cytogfr.2017.06.001","volume":"37","author":"Tsai S.J.","year":"2017","unstructured":"Tsai S.J.; Effects of interleukin-1beta polymorphisms on brain function and behavior in healthy and psychiatric disease conditions. Cytokine Growth Factor Rev  2017,37,89-97","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-7-9","volume":"7","author":"Alboni S.","year":"2010","unstructured":"Alboni S.; Cervia D.; Sugama S.; Conti B.; Interleukin 18 in the CNS. J Neuroinflammation  2010,7(1),9","journal-title":"J Neuroinflammation"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"Milner M.T.","year":"2021","unstructured":"Milner M.T.; Maddugoda M.; G\u00f6tz J.; Burgener S.S.; Schroder K.; The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease. Curr Opin Immunol  2021,68,116-124","journal-title":"Curr Opin Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"Panicker N.","year":"2022","unstructured":"Panicker N.; Kam T.I.; Wang H.; Neifert S.; Chou S.C.; Kumar M.; Brahmachari S.; Jhaldiyal A.; Hinkle J.T.; Akkentli F.; Mao X.; Xu E.; Karuppagounder S.S.; Hsu E.T.; Kang S.U.; Pletnikova O.; Troncoso J.; Dawson V.L.; Dawson T.M.; Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron  2022,110(15),2422-2437.e9","journal-title":"Neuron"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e10248","DOI":"10.15252\/emmm.201810248","volume":"11","author":"Voet S.","year":"2019","unstructured":"Voet S.; Srinivasan S.; Lamkanfi M.; van Loo G.; Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med  2019,11(6),e10248","journal-title":"EMBO Mol Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-020-01848-8","volume":"17","author":"Song A.Q.","year":"2020","unstructured":"Song A.Q.; Gao B.; Fan J.J.; Zhu Y.J.; Zhou J.; Wang Y.L.; Xu L.Z.; Wu W.N.; Wu W.N.; NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. J Neuroinflammation  2020,17(1),178","journal-title":"J Neuroinflammation"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"105122","DOI":"10.1016\/j.neuint.2021.105122","volume":"149","author":"Li Y.K.","year":"2021","unstructured":"Li Y.K.; Chen J.G.; Wang F.; The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders. Neurochem Int  2021,149,105122","journal-title":"Neurochem Int"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/biomedicines10061264","volume":"10","author":"Iban-Arias R.","year":"2022","unstructured":"Iban-Arias R.; Sebastian-Valverde M.; Wu H.; Lyu W.; Wu Q.; Simon J.; Pasinetti G.M.; Role of polyphenol-derived phenolic acid in mitigation of inflammasome-mediated anxiety and depression. Biomedicines  2022,10(6),1264","journal-title":"Biomedicines"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41418-021-00881-1","volume":"29","author":"Flores J.","year":"2022","unstructured":"Flores J.; No\u00ebl A.; Fillion M.L.; LeBlanc A.C.; Therapeutic potential of Nlrp1 inflammasome, caspase-1, or caspase-6 against alzheimer disease cognitive impairment. Cell Death Differ  2022,29(3),657-669","journal-title":"Cell Death Differ"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuropharm.2018.11.022","volume":"146","author":"Li J.M.","year":"2019","unstructured":"Li J.M.; Liu L.L.; Su W.J.; Wang B.; Zhang T.; Zhang Y.; Jiang C.L.; Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors. Neuropharmacology  2019,146,149-153","journal-title":"Neuropharmacology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"749336","DOI":"10.3389\/fimmu.2022.749336","volume":"13","author":"Lee H.","year":"2022","unstructured":"Lee H.; Park J.H.; Hoe H.S.; Idebenone regulates A\u03b2 and LPS-induced neurogliosis and cognitive function through inhibition of NLRP3 Inflammasome\/IL-1\u03b2 axis activation. Front Immunol  2022,13,749336","journal-title":"Front Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"Lonnemann N.","year":"2020","unstructured":"Lonnemann N.; Hosseini S.; Marchetti C.; Skouras D.B.; Stefanoni D.; Dinarello C.A.; Korte M.; The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci  2020,117(50),32145-32154","journal-title":"Proc Natl Acad Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"106559","DOI":"10.1016\/j.intimp.2020.106559","volume":"84","author":"Wu X.L.","year":"2020","unstructured":"Wu X.L.; Deng M.Z.; Gao Z.J.; Dang Y.Y.; Li Y.C.; Li C.W.; Neferine alleviates memory and cognitive dysfunction in diabetic mice through modulation of the NLRP3 inflammasome pathway and alleviation of endoplasmic-reticulum stress. Int Immunopharmacol  2020,84,106559","journal-title":"Int Immunopharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3164\/jcbn.22-105","volume":"73","author":"Li P.","year":"2023","unstructured":"Li P.; He Y.; Yang Q.; Guo H.; Li N.; Zhang D.; NEK7 inhibition attenuates A\u03b242-induced cognitive impairment by regulating TLR4\/NF-\u03baB and the NLRP3 inflammasome in mice. J Clin Biochem Nutr  2023,73(2),145-153","journal-title":"J Clin Biochem Nutr"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40035-023-00381-x","volume":"12","author":"Xu Y.","year":"2023","unstructured":"Xu Y.; Yang Y.; Chen X.; Jiang D.; Zhang F.; Guo Y.; Hu B.; Xu G.; Peng S.; Wu L.; Hu J.; NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors. Transl Neurodegener  2023,12(1),49","journal-title":"Transl Neurodegener"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/JCP.0000000000001242","volume":"40","author":"Bruno A.","year":"2020","unstructured":"Bruno A.; Zoccali R.A.; Troili G.M.; Scala L.; Pandolfo G.; Cedro C.; Mento C.; Santoro V.; Spina E.; Muscatello M.R.A.; Vortioxetine on cognition in schizophrenia. J Clin Psychopharmacol  2020,40(4),381-385","journal-title":"J Clin Psychopharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.9758\/cpn.2022.20.2.311","volume":"20","author":"Jeong H.W.","year":"2022","unstructured":"Jeong H.W.; Yoon K.H.; Lee C.H.; Moon Y.S.; Kim D.H.; Vortioxetine treatment for depression in alzheimer\u2019s disease: A randomized, double-blind, placebo-controlled study. Clin Psychopharmacol Neurosci  2022,20(2),311-319","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"108977","DOI":"10.1016\/j.neuropharm.2022.108977","volume":"208","author":"Nemutlu Samur D.","year":"2022","unstructured":"Nemutlu Samur D.; Ak\u00e7ay G.; Y\u0131ld\u0131r\u0131m S.; \u00d6zkan A.; \u00c7eker T.; Derin N.; Tanr\u0131\u00f6ver G.; Aslan M.; A\u011far A.; \u00d6zbey G.; Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson\u2019s disease via targeting TLR-2 mediated neuroinflammation. Neuropharmacology  2022,208,108977","journal-title":"Neuropharmacology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fpsyt.2019.00771","volume":"10","author":"Bennabi D.","year":"2019","unstructured":"Bennabi D.; Haffen E.; Van Waes V.; Vortioxetine for cognitive enhancement in major depression: From animal models to clinical research. Front Psychiatry  2019,10,771","journal-title":"Front Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/brainsci12111466","volume":"12","author":"Santos Garc\u00eda D.","year":"2022","unstructured":"Santos Garc\u00eda D.; Alonso Losada M.G.; Cimas Hernando I.; Cabo L\u00f3pez I.; Y\u00e1\u00f1ez Ba\u00f1a R.; Alonso Redondo R.; Paz Gonz\u00e1lez J.M.; Cores Bartolom\u00e9 C.; Feal Painceiras M.J.; \u00cd\u00f1iguez Alvarado M.C.; Labandeira C.; Garc\u00eda D\u00edaz I.; Vortioxetine improves depressive symptoms and cognition in parkinson\u2019s disease patients with major depression: An open-label prospective study. Brain Sci  2022,12(11),1466","journal-title":"Brain Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"603979","DOI":"10.3389\/fphar.2020.603979","volume":"11","author":"Alboni S.","year":"2021","unstructured":"Alboni S.; Benatti C.; Colliva C.; Radighieri G.; Blom J.M.C.; Brunello N.; Tascedda F.; Vortioxetine prevents lipopolysaccharide-induced memory impairment without inhibiting the initial inflammatory cascade. Front Pharmacol  2021,11,603979","journal-title":"Front Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5582\/bst.2020.01029","volume":"14","author":"Liu G.","year":"2020","unstructured":"Liu G.; Chen X.; Wang Q.; Yuan L.; NEK7: A potential therapy target for NLRP3-related diseases. Biosci Trends  2020,14(2),74-82","journal-title":"Biosci Trends"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pbb.2015.05.013","volume":"135","author":"Li Y.","year":"2015","unstructured":"Li Y.; Abdourahman A.; Tamm J.A.; Pehrson A.L.; S\u00e1nchez C.; Gulinello M.; Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice. Pharmacol Biochem Behav  2015,135,70-82","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2018.09.019","volume":"74","author":"Rigillo G.","year":"2018","unstructured":"Rigillo G.; Vilella A.; Benatti C.; Schaeffer L.; Brunello N.; Blom J.M.C.; Zoli M.; Tascedda F.; LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response. Brain Behav Immun  2018,74,277-290","journal-title":"Brain Behav Immun"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.33549\/physiolres.933480","volume":"66","author":"Zakaria R.","year":"2017","unstructured":"Zakaria R.; Wan Yaacob W.M.H.; Othman Z.; Long I.; Ahmad A.H.; Al-Rahbi B.; Lipopolysaccharide-induced memory impairment in rats: A model of Alzheimer\u2019s disease. Physiol Res  2017,66(4),553-565","journal-title":"Physiol Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","volume":"25","author":"Cunningham C.","year":"2005","unstructured":"Cunningham C.; Wilcockson D.C.; Campion S.; Lunnon K.; Perry V.H.; Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci  2005,25(40),9275-9284","journal-title":"J Neurosci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bbr.2010.10.036","volume":"217","author":"Tarr A.J.","year":"2011","unstructured":"Tarr A.J.; McLinden K.A.; Kranjac D.; Kohman R.A.; Amaral W.; Boehm G.W.; The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1\u03b2 expression. Behav Brain Res  2011,217(2),481-485","journal-title":"Behav Brain Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","volume":"9","author":"Zhao J.","year":"2019","unstructured":"Zhao J.; Bi W.; Xiao S.; Lan X.; Cheng X.; Zhang J.; Lu D.; Wei W.; Wang Y.; Li H.; Fu Y.; Zhu L.; Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep  2019,9(1),5790","journal-title":"Sci Rep"},{"key":"ref=43","first-page":"321","volume":"47","author":"Jacewicz M.","year":"2009","unstructured":"Jacewicz M.; Czapski G.A.; Katkowska I.; Strosznajder R.P.; Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. Folia Neuropathol  2009,47(4),321-328","journal-title":"Folia Neuropathol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnins.2014.00083","volume":"8","author":"Valero J.","year":"2014","unstructured":"Valero J.; Mastrella G.; Neiva I.; S\u00e1nchez S.; Malva J.O.; Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory. Front Neurosci  2014,8,83","journal-title":"Front Neurosci"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","volume":"32","author":"Frenois F.","year":"2007","unstructured":"Frenois F.; Moreau M.; O\u2019 Connor J.; Lawson M.; Micon C.; Lestage J.; Kelley K.W.; Dantzer R.; Castanon N.; Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology  2007,32(5),516-531","journal-title":"Psychoneuroendocrinology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"O\u2019Connor J.C.","year":"2009","unstructured":"O\u2019Connor J.C.; Lawson M.A.; Andr\u00e9 C.; Moreau M.; Lestage J.; Castanon N.; Kelley K.W.; Dantzer R.; Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry  2009,14(5),511-522","journal-title":"Mol Psychiatry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.3892\/mmr.2018.8520","volume":"17","author":"Zhao L.R.","year":"2018","unstructured":"Zhao L.R.; Xing R.L.; Wang P.M.; Zhang N.S.; Yin S.J.; Li X.C.; Zhang L.; NLRP1 and NLRP3 inflammasomes mediate LPS\/ATP induced pyroptosis in knee osteoarthritis. Mol Med Rep  2018,17(4),5463-5469","journal-title":"Mol Med Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"01251","DOI":"10.3389\/fphar.2020.01251","volume":"11","author":"Xie L.","year":"2020","unstructured":"Xie L.; Gu Z.; Liu H.; Jia B.; Wang Y.; Cao M.; Song R.; Zhang Z.; Bian Y.; The anti-depressive effects of hesperidin and the relative mechanisms based on the NLRP3 inflammatory signaling pathway. Front Pharmacol  2020,11,01251","journal-title":"Front Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"113987","DOI":"10.1016\/j.bbr.2022.113987","volume":"432","author":"Li M.M.","year":"2022","unstructured":"Li M.M.; Wang X.; Chen X.D.; Yang H.L.; Xu H.S.; Zhou P.; Gao R.; Zhang N.; Wang J.; Jiang L.; Liu N.; Lysosomal dysfunction is associated with NLRP3 inflammasome activation in chronic unpredictable mild stress-induced depressive mice. Behav Brain Res  2022,432,113987","journal-title":"Behav Brain Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2119\/molmed.2014.00147","volume":"20","author":"Silverman H.A.","year":"2014","unstructured":"Silverman H.A.; Dancho M.; Regnier-Golanov A.; Nasim M.; Ochani M.; Olofsson P.S.; Ahmed M.; Miller E.J.; Chavan S.S.; Golanov E.; Metz C.N.; Tracey K.J.; Pavlov V.A.; Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation. Mol Med  2014,20(1),601-611","journal-title":"Mol Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.2147\/JIR.S362006","volume":"15","author":"Jung H.","year":"2022","unstructured":"Jung H.; Lee H.; Kim D.; Cheong E.; Hyun Y.M.; Yu J.W.; Um J.W.; Differential regional vulnerability of the brain to mild neuroinflammation induced by systemic LPS treatment in mice. J Inflamm Res  2022,15,3053-3063","journal-title":"J Inflamm Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/glia.20663","volume":"56","author":"de Haas A.H.","year":"2008","unstructured":"de Haas A.H.; Boddeke H.W.G.M.; Biber K.; Region\u2010specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia  2008,56(8),888-894","journal-title":"Glia"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nn.4222","volume":"19","author":"Grabert K.","year":"2016","unstructured":"Grabert K.; Michoel T.; Karavolos M.H.; Clohisey S.; Baillie J.K.; Stevens M.P.; Freeman T.C.; Summers K.M.; McColl B.W.; Microglial brain region\u2212dependent diversity and selective regional sensitivities to aging. Nat Neurosci  2016,19(3),504-516","journal-title":"Nat Neurosci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2017.06.020","volume":"95","author":"De Biase L.M.","year":"2017","unstructured":"De Biase L.M.; Schuebel K.E.; Fusfeld Z.H.; Jair K.; Hawes I.A.; Cimbro R.; Zhang H.Y.; Liu Q.R.; Shen H.; Xi Z.X.; Goldman D.; Bonci A.; Local cues establish and maintain region-specific phenotypes of basal ganglia microglia. Neuron  2017,95(2),341-356.e6","journal-title":"Neuron"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","volume":"21","author":"Ayata P.","year":"2018","unstructured":"Ayata P.; Badimon A.; Strasburger H.J.; Duff M.K.; Montgomery S.E.; Loh Y.H.E.; Ebert A.; Pimenova A.A.; Ramirez B.R.; Chan A.T.; Sullivan J.M.; Purushothaman I.; Scarpa J.R.; Goate A.M.; Busslinger M.; Shen L.; Losic B.; Schaefer A.; Epigenetic regulation of brain region-specific microglia clearance activity. Nat Neurosci  2018,21(8),1049-1060","journal-title":"Nat Neurosci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41598-018-20643-3","volume":"8","author":"Furube E.","year":"2018","unstructured":"Furube E.; Kawai S.; Inagaki H.; Takagi S.; Miyata S.; Brain region-dependent heterogeneity and dose-dependent difference in transient microglia population increase during lipopolysaccharide-induced inflammation. Sci Rep  2018,8(1),2203","journal-title":"Sci Rep"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","volume":"30","author":"Masuda T.","year":"2020","unstructured":"Masuda T.; Sankowski R.; Staszewski O.; Prinz M.; Microglia heterogeneity in the single-cell era. Cell Rep  2020,30(5),1271-1281","journal-title":"Cell Rep"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"910988","DOI":"10.3389\/fnagi.2022.910988","volume":"14","author":"Brandi E.","year":"2022","unstructured":"Brandi E.; Torres-Garcia L.; Svanbergsson A.; Haikal C.; Liu D.; Li W.; Li J.Y.; Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure. Front Aging Neurosci  2022,14,910988","journal-title":"Front Aging Neurosci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.20160933","volume":"214","author":"Stutz A.","year":"2017","unstructured":"Stutz A.; Kolbe C.C.; Stahl R.; Horvath G.L.; Franklin B.S.; van Ray O.; Brinkschulte R.; Geyer M.; Meissner F.; Latz E.; NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J Exp Med  2017,214(6),1725-1736","journal-title":"J Exp Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","volume":"15","author":"Franklin B.S.","year":"2014","unstructured":"Franklin B.S.; Bossaller L.; De Nardo D.; Ratter J.M.; Stutz A.; Engels G.; Brenker C.; Nordhoff M.; Mirandola S.R.; Al-Amoudi A.; Mangan M.S.; Zimmer S.; Monks B.G.; Fricke M.; Schmidt R.E.; Espevik T.; Jones B.; Jarnicki A.G.; Hansbro P.M.; Busto P.; Marshak-Rothstein A.; Hornemann S.; Aguzzi A.; Kastenm\u00fcller W.; Latz E.; The adaptor ASC has extracellular and \u2018prionoid\u2019 activities that propagate inflammation. Nat Immunol  2014,15(8),727-737","journal-title":"Nat Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1038\/ncomms11929","volume":"7","author":"Dick M.S.","year":"2016","unstructured":"Dick M.S.; Sborgi L.; R\u00fchl S.; Hiller S.; Broz P.; ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat Commun  2016,7(1),11929","journal-title":"Nat Commun"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"752482","DOI":"10.3389\/fimmu.2021.752482","volume":"12","author":"Nagar A.","year":"2021","unstructured":"Nagar A.; Rahman T.; Harton J.A.; The ASC speck and NLRP3 inflammasome function are spatially and temporally distinct. Front Immunol  2021,12,752482","journal-title":"Front Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1007\/s00213-022-06201-w","volume":"239","author":"Lyu D.","year":"2022","unstructured":"Lyu D.; Wang F.; Zhang M.; Yang W.; Huang H.; Huang Q.; Wu C.; Qian N.; Wang M.; Zhang H.; Zheng S.; Chen J.; Fu Y.; Zhang C.; Li Z.; Hong W.; Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway. Psychopharmacology  2022,239(10),3201-3212","journal-title":"Psychopharmacology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1523\/JNEUROSCI.23-04-01517.2003","volume":"23","author":"Lee I.","year":"2003","unstructured":"Lee I.; Kesner R.P.; Time-dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory. J Neurosci  2003,23(4),1517-1523","journal-title":"J Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"Rev-1292","DOI":"10.12688\/f1000research.19317.1","volume":"F1000","author":"Yavas E.","year":"2019","unstructured":"Yavas E.; Gonzalez S.; Fanselow M.S.; Interactions between the hippocampus, prefrontal cortex, and amygdala support complex learning and memory. F1000 Res  2019,F1000,Rev-1292","journal-title":"F1000 Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.neuron.2018.01.016","volume":"97","author":"Jimenez J.C.","year":"2018","unstructured":"Jimenez J.C.; Su K.; Goldberg A.R.; Luna V.M.; Biane J.S.; Ordek G.; Zhou P.; Ong S.K.; Wright M.A.; Zweifel L.; Paninski L.; Hen R.; Kheirbek M.A.; Anxiety cells in a hippocampal-hypothalamic circuit. Neuron  2018,97(3),670-683.e6","journal-title":"Neuron"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7","volume":"8","author":"Moser M-B.","year":"1998","unstructured":"Moser M-B.; Moser E.I.; Functional differentiation in the hippocampus. Hippocampus  1998,8(6),608-619","journal-title":"Hippocampus"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1101\/lm.025213.111","volume":"19","author":"Sannino S.","year":"2012","unstructured":"Sannino S.; Russo F.; Torromino G.; Pendolino V.; Calabresi P.; De Leonibus E.; Role of the dorsal hippocampus in object memory load. Learn Mem  2012,19(5),211-218","journal-title":"Learn Mem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e2208254119","DOI":"10.1073\/pnas.2208254119","volume":"119","author":"G\u00e1lvez-M\u00e1rquez D.K.","year":"2022","unstructured":"G\u00e1lvez-M\u00e1rquez D.K.; Salgado-M\u00e9nez M.; Moreno-Castilla P.; Rodr\u00edguez-Dur\u00e1n L.; Escobar M.L.; Tecuapetla F.; Bermudez-Rattoni F.; Spatial contextual recognition memory updating is modulated by dopamine release in the dorsal hippocampus from the locus coeruleus. Proc Natl Acad Sci  2022,119(49),e2208254119","journal-title":"Proc Natl Acad Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1007\/s12035-018-1458-1","volume":"56","author":"Trojan E.","year":"2019","unstructured":"Trojan E.; Chamera K.; Bryniarska N.; Kotarska K.; Le\u015bkiewicz M.; Regulska M.; Basta-Kaim A.; Role of chronic administration of antidepressant drugs in the prenatal stress-evoked inflammatory response in the brain of adult offspring rats: Involvement of the NLRP3 inflammasome-related pathway. Mol Neurobiol  2019,56(8),5365-5380","journal-title":"Mol Neurobiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"102515","DOI":"10.1016\/j.jaut.2020.102515","volume":"113","author":"Zhao N.","year":"2020","unstructured":"Zhao N.; Li C.; Di B.; Xu L.; Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors. J Autoimmun  2020,113,102515","journal-title":"J Autoimmun"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1101\/799320","author":"Schmacke N.A.","year":"2019","unstructured":"Schmacke N.A.; Gaidt M.M.; Szymanska I.; O\u2019duill F.; Stafford C.A.; Chauhan D.; Fr\u00f6hlich A.L.; Nagl D.; Pinci F.; Schmid-Burgk J.L.; Hornung V.; Priming enables a NEK7-independent route of NLRP3 activation. bioRxiv  2019","journal-title":"bioRxiv"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1002\/ptr.7518","volume":"36","author":"Liang L.","year":"2022","unstructured":"Liang L.; Wang H.; Hu Y.; Bian H.; Xiao L.; Wang G.; Oridonin relieves depressive\u2010like behaviors by inhibiting neuroinflammation and autophagy impairment in rats subjected to chronic unpredictable mild stress. Phytother Res  2022,36(8),3335-3351","journal-title":"Phytother Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"155159","DOI":"10.1016\/j.phymed.2023.155159","volume":"122","author":"Fang Z.E.","year":"2024","unstructured":"Fang Z.E.; Wang Y.; Bian S.; Qin S.; Zhao H.; Wen J.; Liu T.; Ren L.; Li Q.; Shi W.; Zhao J.; Yang H.; Peng R.; Wang Q.; Bai Z.; Xu G.; Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases. Phytomedicine  2024,122,155159","journal-title":"Phytomedicine"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"103728","DOI":"10.1016\/j.nsa.2023.103728","volume":"2","author":"Rigillo G.","year":"2023","unstructured":"Rigillo G.; Ciani M.; Benatti C.; Blom J.M.C.; Tascedda F.; Pani L.; Alboni S.; Brunello N.; Vortioxetine attenuates neuroinflammation by modulating the NOD-like receptor family pyrin domain containing 3 inflammasome activation in microglia: implications for cognitive function. Neurosci Appl  2023,2,103728","journal-title":"Neurosci Appl"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666240705143649","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231655\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666240705143649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:15:03Z","timestamp":1733728503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231655\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x22666240705143649","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}